Physician profile
Brian Cho
NPI 1356769533
$2,223.93
in general payments reported to CMS, 2019-2025
11 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2022: $1,482 · 2023: $58.33 · 2024: $390 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,463.07 | 2022 | |
| Allergan, INC. | $141.62 | 2019 | |
| Globus Medical, INC. | $130.54 | 2024 | Mars 3v/3vl, Creo One Robotic Screw, Coalition Agx / Agx Rp |
| Supreme Orthopedic Systems, LLC | $122.68 | 2024 | |
| Endo USA, INC. | $120.84 | 2024 | Xiaflex |
| Trimed, INC. | $100.26 | 2025 | |
| Sanara Medtech INC. | $53.61 | 2022-2023 | Celleraterx |
| Solventum Corporation | $30.73 | 2025 | Activ.A.C. |
| Endo Pharmaceuticals INC. | $23.74 | 2023 | Xiaflex |
| Mimedx Group, INC. | $20.50 | 2025 | |
| Smith+Nephew, INC. | $16.34 | 2024 | Oasis, Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.